Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....
Digital Biomarkers Market: By Products, By Application, By End-users, Region Forecast 2019-2030
Digital Biomarkers Market size is valued at US$ 1,243.3 million in 2023 and is expected to reach US$ 1442.45 million by 2030, at a CAGR of 41.12% during the forecast period 2024-2030. Biomarkers are objective assessments that capture physiological, anatomic, and pathological aspects of an individual in order to understand the person's state and the body's warning signs. Digital biomarkers are measurable behavioural and physiological data collected and assessed using digital devices including wearables, digestibles, implantables, and portables. Digital biomarkers help to provide increased imaging capabilities as well as improved spatial resolution. Stomach aortic aneurysm, aortic analyzation, difficult fringe vein ailment, and carotid conduit sickness are among the services provided by digital biomarkers.
Digital biomarkers are physiological and behavioural data that are gathered and measured using digital devices such as portables, wearables, implantables, or digestibles. Typically, the information gathered is utilised to explain, affect, and/or forecast health-related outcomes. this report studies global Market dynamics elaborately to identify the current trends & drivers, future opportunities and possible challenges to the key stakeholders operating in the market. In addition, The global market report includes human demographics; regulatory scenario, and competition analysis with vividly illustrated the competition dashboard to assess the market competition. Moreover, PBI analyzed global market to better equip clients with possible investment opportunities across the regions (regional Investment Hot-Spots) and market unmet needs (Product opportunities).
Study Period
2024-2030Base Year
2023CAGR
41.12%Largest Market
North-AmericaFastest Growing Market
Europe
An increase in the use of connected digital devices and health-related mobile applications can be credited to the growth of the digital biomarkers industry. These devices can help with a variety of diagnostic and prognostic assessments in a variety of illness areas, such as mental health, diabetes, neurological diseases, and cardiovascular diseases. The digital biomarkers industry is being boosted by the increasing use of smartphones and the introduction of smartwatches, which aid in tracking physiological parameters of a person's health. The digital biomarkers industry is being propelled forward by technological advancements in mobile phones and digitally connected technology.
Report Benchmarks |
Details |
Report Study Period |
2024-2030 |
Market Size in 2023 |
US$ 1,243.3 million |
Market Size in 2030 |
US$ 1442.45 million |
Market CAGR |
41.12% |
By Product |
|
By Application |
|
By End User |
|
By Region |
|
Download Free Sample Report
Digital biomarkers market size was valued at US$ 1,243.3 million in 2023 and is set to reach US$ 1442.45 million by 2030, at a CAGR of 41.12%
The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).
In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.
The Digital Biomarkers Market is experiencing a growing trend of leveraging wearable devices and digital health technologies to monitor and analyze patients' health data for disease management and treatment optimization.
Key Market Players